Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last 3,198 INR
Change Today -75.05 / -2.29%
Volume 13.4K
GLXO On Other Exchanges
Symbol
Exchange
Natl India
OTC US
As of 7:05 AM 04/20/15 All times are local (Market data is delayed by at least 15 minutes).

glaxosmithkline pharmaceutic (GLXO) Snapshot

Open
3,282
Previous Close
3,273
Day High
3,282
Day Low
3,180
52 Week High
01/27/15 - 3,550
52 Week Low
06/26/14 - 2,352
Market Cap
270.9B
Average Volume 10 Days
16.8K
EPS TTM
56.87
Shares Outstanding
84.7M
EX-Date
04/3/14
P/E TM
56.2x
Dividend
--
Dividend Yield
1.56%
Current Stock Chart for GLAXOSMITHKLINE PHARMACEUTIC (GLXO)

Related News

No related news articles were found.

glaxosmithkline pharmaceutic (GLXO) Related Businessweek News

No Related Businessweek News Found

glaxosmithkline pharmaceutic (GLXO) Details

GlaxoSmithKline Pharmaceuticals Limited operates as research-based healthcare and pharmaceutical company worldwide. It manufactures, distributes, and trades prescription medicines for a range of therapeutic areas, including analgesic, anti-infective, anti-inflammatory, anti-parasitic, cardiovascular, dermatology, diabetes, endocrine, gastrointestinal, gynaecology, immunosupressants, nutritional, respiratory, CNS, and oncology diseases. The company also offers vaccines for the prevention of various diseases comprising hepatitis A, hepatitis B, invasive disease caused by H, influenzae, chickenpox, diphtheria, pertussis, tetanus, rotavirus, cervical cancer, streptococcus pneumonia, and others. GlaxoSmithKline Pharmaceuticals Limited was founded in 1924 and is based in Mumbai, India.

5,034 Employees
Last Reported Date: 03/20/14
Founded in 1924

glaxosmithkline pharmaceutic (GLXO) Top Compensated Officers

Managing Director, Executive Director and Mem...
Total Annual Compensation: 26.1M
Executive Director of Technical and Executive...
Total Annual Compensation: 7.0M
Executive Director of Human Resources and Exe...
Total Annual Compensation: 7.2M
Compensation as of Fiscal Year 2013.

glaxosmithkline pharmaceutic (GLXO) Key Developments

GlaxoSmithkline Pharmaceuticals Limited Announces Unaudited Standalone Earnings Results for the Fourth Quarter and Year Ended December 31, 2014

GlaxoSmithkline Pharmaceuticals Limited announced unaudited standalone earnings results for the fourth quarter and year ended December 31, 2014. For the quarter, on standalone basis, the company reported net sales, (net of excise duty) of INR 6,461.5 million compared to INR 6,306.3 million a year ago. Profit from operations before other income and exceptional items were INR 1,088.2 million compared to INR 1,124.7 million a year ago. Profit from ordinary activities before tax was INR 1,005.2 million compared to INR 1,686.7 million a year ago. Net profit from ordinary activities was INR 453.0 million or INR 5.3 per share compared to INR 1,168.8 million or INR 13.8 per share a year ago. For the year, on standalone basis the company reported net sales, net of excise duty of INR 26,399.4 million compared to INR 25,201.7 million a year ago. Profit from operations before other income and exceptional items were INR 4,808.2 million compared to INR 5,022.0 million a year ago. Profit from ordinary activities before tax was INR 5,929.4 million compared to INR 7,293.2 million a year ago. Net profit from ordinary activities was INR 3,688.0 million or INR 43.5 per share compared to INR 5,018.8 million or INR 59.3 per share a year ago.

GlaxoSmithkline Pharmaceuticals Limited, Board Meeting, Feb 12, 2015

GlaxoSmithkline Pharmaceuticals Limited, Board Meeting, Feb 12, 2015. Agenda: To consider unaudited financial results for the fourth quarter ended December 31, 2014; and to consider the approval of the shareholders' through postal ballot for appointment of seven independent directors and re-appointment and appointment of its whole-time directors.

GlaxoSmithkline Pharmaceuticals Limited to Report Q4, 2014 Results on Feb 12, 2015

GlaxoSmithkline Pharmaceuticals Limited announced that they will report Q4, 2014 results on Feb 12, 2015

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
GLXO:IN 3,198.40 INR -75.05

GLXO Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for GLXO.
View Industry Companies
 

Industry Analysis

GLXO

Industry Average

Valuation GLXO Industry Range
Price/Earnings -- Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow -- Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact GLAXOSMITHKLINE PHARMACEUTIC, please visit www.gsk-india.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.